Vitamin D Intoxication with Hypercalcemia Due to Overuse of Supplement
We describe a patient with hypercalcemia associated with the injection of high doses vitamin D as supplement for a period of six months. A 76-year-old woman had been taking an intramuscular injection of vitamin D 300,000 IU every ten days for six months. She was hospitalized with symptoms of hypercalcemia: chronic constipation, unstable gait, a chronic generalized musculoskeletal pain and increased fatigue. On admission her 25 (OH) vitamin D and Calcium levels were 559 nmol/L and 13.85 mg/dL respectively, and Parathyroid Hormone (PTH) level was 7.1 pg/mL. Immediately she received diuresis therapy with saline and furosemide in conjunction with calcitonin and pamidronate. At discharge her serum calcium level was 11.5 mg/dL. To lower endogenous overproduction of calcitriol, prednisolone 20 mg/day for 10 days was administered at discharge time.
Hoff WV. Vitamin-D poisoning. Lancet 1980; 1(8181):1308.
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69(5):842-56.
Bilezikian JP. Clinical review 51: Management of hypercalcemia. J Clin Endocrinol Metab 1993; 77(6):1445-9.
Nussbaum SR, Younger J, Vandepol CJ, et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages. Am J Med 1993; 95(3):297- 304.
Bringhurst FR, Demay MB, Kronenberg HM. Hormones and Disorders of Mineral Metabolism. In: Kronenberg HM, Williams Textbook of Endocrinology. Available from http://www.mdconsult.com/das/book/ body/224568056-8/1075882147/1555/168.html#4-u1.0-B978-1-4160- 2911-3.50029-7-cesec32_2499 Accessed October 29, 2010.
Institute of Medicine. Report at a Glance, Report Brief: Dietary Reference Intakes for Calcium and Vitamin D, released 11/30/2010; Available from: URL: http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for- Calcium-and-Vitamin-D/Report-Brief.aspx (Accessed on December 01, 2010).
Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337(10):670-6.
Dawson-Hughes B. Calcium and vitamin D nutritional needs of elderly women. J Nutr 1996; 126(4 Suppl.):1165S-7S.
Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly woman. N Engl J Med 1992; 327(23):1637-42.
Adams JS, Lee G. Gains in bone mineral density with resolution of vitamin D intoxication. Ann Intern Med 1997; 127(3):203-6.
Woolliscroft JO. Megavitamins: fact and fancy. Dis Mon 1983; 29(5):1-56
Mason RS, Lissner D, Grunstein HS, Posen S. A simplified assay for dihydroxylated vitamin D metabolites in human serum: application to hyper- and hypovitaminosis D. Clin Chem 1980; 26(3):444-50.
Gertner JM, Domenech M. 25-hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol. Clin Pathol 1977; 30(2):144-50.
Hughes MR, Baylink DJ, Jones PG, Haussler MR. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25- dihydroxyvitamin D2/ D3. J Clin Invest 1976; 58(1):61-70.
Rizzoli R, Stoermann C, Ammann P, Bonjour JP. Hypercalcemia and hyperosteolysis in vitamin D intoxication: effects of clodronate therapy. Bone 1994; 15(2):193-8.
Vieth R.The mechanisms of vitamin D toxicity. Bone Miner 1990; 11(3):267-72.
Jacobus CH, Holick MF, Shao Q, et al. Hypervitaminosis associated with drinking milk. N Engl J Med 1992; 326(18):1173-7.
The Relationship Between Serum 25(OH) D and Parathyroid Hormone Levels. Saliba W, Barnett O, Rennert HS, Lavi I, Rennert G. Am J Med 2011; 124(12):1165-70.
Hosking DJ, Cowley A, Bucknall CA. Rehydration in the treatment of severe hypercalcaemia. Q J Med 1981; 50(200):473-81.
Suki WN, Yium JJ, Von Minden M, et al. Acute treatment of hypercalcemia with furosemide. N Engl J Med 1970; 283(16):836-40.
Wisneski LA. Salmon calcitonin in the acute management of hypercalcemia. Calcif Tissue Int 1990; 46 Suppl: S26-30.
Austin LA, Heath H 3rd. Calcitonin: physiology and pathophysiology. N Engl J Med 1981; 304(5):269-78.
Deftos LJ, First BP. Calcitonin as a drug. Ann Intern Med 1981; 95(2):192-7
McIntyre HD, Cameron DP, Urquhart SM, Davies WE. Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy. Postgrad Med J 1989; 65(762):244-6.
Carano A, Teitelbaum SL, Konsek JD, et al. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 1990; 85(2):456-61.
Shane, E, Dinaz, I. Hypercalcemia: pathogenesis, clinical manifestations, differential diagnosis, and management. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (Sixth Edition). American Society of Bone and Mineral Research 2006; 179.
Copyright (c) 2015 Journal of Pharmaceutical Care
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.